Text Size

Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium

This study is currently recruiting participants.
Verified August 2011 by Universiteit Antwerpen
Sponsor:
Collaborator:
Belgian Government
Information provided by:
Universiteit Antwerpen
ClinicalTrials.gov Identifier:
NCT00727623
First received: July 29, 2008
Last updated: August 10, 2011
Last verified: August 2011
History of Changes
  Purpose

The purpose of this observational study is to assess predictors of in-hospital mortality in patients with acute myocardial infarction admitted to Belgian hospitals.


Condition
Acute Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Observational Study to Assess Predictors of in Hospital Mortality in STEMI Patients Admitted in Belgian Hospitals

Resource links provided by NLM:

MedlinePlus related topics: Heart Attack
U.S. FDA Resources

Further study details as provided by Universiteit Antwerpen:

Primary Outcome Measures:
  • all cause mortality [ Time Frame: one month ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: July 2007
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with acute ST elevation myocardial infarction admitted in Belgian hospitals.

Criteria

Inclusion Criteria:

  • clinical diagnosis of acute myocardial infarction with ST elevation or left bundle branch blok pattern on ECG

Exclusion Criteria:

  • acute myocardial infarction as an acute complication of coronary intervention
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00727623

Contacts
Contact: Marc J Claeys, MD PhD 3238214706 marc.claeys@ua.ac.be
Contact: Christiaan M Vrints, MD PhD 3238214720 christiaan.vrints@ua.ac.be

Locations
Belgium
Centre Hospitalier de Jolimont Recruiting
La Louviere, Hainaut, Belgium, 7100
Contact: Antoine de Meester, MD     32 64 233011     antoine.demeester@skynet.be    
Sponsors and Collaborators
Universiteit Antwerpen
Belgian Government
Investigators
Principal Investigator: Marc J Claeys, MD.PhD University Hospital, Antwerp
  More Information

No publications provided

Responsible Party: Prof Dr M Claeys, Universiteit Antwerpen
ClinicalTrials.gov Identifier: NCT00727623     History of Changes
Other Study ID Numbers: BIWAC-01
Study First Received: July 29, 2008
Last Updated: August 10, 2011
Health Authority: Belgium: Ministry of Social Affairs, Public Health and the Environment

Keywords provided by Universiteit Antwerpen:
acute coronary syndrome
myocardial infarction
predictors of mortality
reperfusion therapy

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
 Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013